- Report
- March 2024
- 189 Pages
Global
From €3259EUR$3,374USD£2,787GBP
€3621EUR$3,749USD£3,097GBP
- Report
- December 2023
- 120 Pages
Global
From €5747EUR$5,950USD£4,915GBP
- Report
- January 2024
- 200 Pages
Global
From €3864EUR$4,000USD£3,304GBP
- Report
- May 2024
- 188 Pages
Global
From €4782EUR$4,950USD£4,089GBP
- Report
- November 2023
- 145 Pages
Global
From €2414EUR$2,499USD£2,064GBP
- Report
- April 2024
- 180 Pages
Global
From €4733EUR$4,900USD£4,047GBP
- Report
- July 2023
- 220 Pages
Global
€4439EUR$4,595USD£3,795GBP
- Report
- February 2024
- 120 Pages
Global
From €4588EUR$4,750USD£3,923GBP
- Report
- April 2020
- 141 Pages
Global
From €4782EUR$4,950USD£4,089GBP
- Report
- March 2024
- 150 Pages
From €5013EUR$5,190USD£4,287GBP
- Report
- March 2023
- 159 Pages
Global
From €2415EUR$2,500USD£2,065GBP
- Report
- August 2021
- 107 Pages
Global
From €3200EUR$3,549USD£2,832GBP
Drug Discovery Informatics is a field of research that focuses on the development of software and databases to support the drug discovery process. It involves the integration of data from multiple sources, such as biological, chemical, and clinical data, to enable the identification of potential drug targets and the development of new drugs. Drug Discovery Informatics also includes the development of algorithms and software tools to analyze and interpret data, as well as the development of predictive models to identify potential drug candidates.
Drug Discovery Informatics is an important part of the drug discovery process, as it enables the efficient and effective analysis of large amounts of data. It also helps to reduce the cost and time associated with drug discovery, as well as to improve the accuracy of drug discovery.
Some companies in the Drug Discovery Informatics market include IBM, Microsoft, Oracle, Infor, and Accenture. Show Less Read more